The latest news for pharma industry insiders.
In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, explains which specific endpoints they'll be looking at in the Phase I trial to assess LP-284's potential efficacy and how the insights gained will be fed back into RADR®
Ongoing and active shortages are currently at the highest number since January 2001.
It’s hard to get your head around all the things artificial intelligence will do, someday. So instead focus on how it can make your life better right now.
Two-day event will convene industry leaders to explore strategies to overcome challenges across the product lifecycle — from R&D to global commercialization
If you sit too much, your brain could look just like that of someone with dementia. Sitting also raises your risk of heart disease, diabetes, stroke, high blood pressure, and high cholesterol. https://wb.md/44zGWOX
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
